31 Oct, 2014
Funds vaccine to counter airborne exposure
EbolaPentagon0 Comments
0
0
reuben
reuben2014-11-01 09:26:302015-03-20 04:34:42Funds vaccine to counter airborne exposureThe Pentagon provides a $9.5 million funding grant to the Profectus BioSciences to manufacture trivalent VesiculoVax™-vectored vaccine. Statement:
The lyophilized trivalent vaccine is being tested in both pre-exposure and post-exposure studies to confirm protection of non-human primates from aerosol exposure to Ebola and Marburg viruses.
Subscribe
Login
0 Comments
